Lightship, a Los Angeles, CA-based provider of enterprise level, direct-to-patient clinical research solutions, raised $20m im Series B funding.
The round was led by McKesson Ventures and Define Ventures with participation from Khosla Ventures, Brook Byers, and Marc Benioff.
The company intends to use the funds to continue to build the team to deliver Direct-to-Patient clinical research, and further develop its clinical research technology platform.
Led by David MacMurchy, CEO, Tom Pike, Executive Chairman, and Co-Founder Alon Krashinsky, Lightship is a provider of enterprise level, direct-to-patient clinical research solutions. It engages patients at home to make taking part in clinical research more accessible for everyone. The company uses modern technology and an integrated digital platform that allows patients to engage with doctors, coordinators, and nurses at all phases of the study.